Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Autores
PADULLA, Georgia A.
CERQUEIRA, Ana Maria Mosca de
SOUSA, Adriana Martins de
SANDES, Alex Freire
TRAINA, Fabiola
NOGUEIRA, Frederico Lisboa
PEREIRA, Grazielly de Fathima
BOECHAT, jose Laerte
Citação
HEMATOLOGY TRANSFUSION AND CELL THERAPY, v.44, n.4, p.582-594, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Systemic Mastocytosis comprises a group of neoplastic diseases character-ized by clonal expansion and infiltration of mast cells into several organs. The diagnosis and treatment of this disease may be challenging for non-specialists. Objective: Make suggestions or recommendations in Systemic Mastocytosis based in a panel of Brazil-ian specialists.Method and results: An online expert panel with 18 multidisciplinary specialists was con-vened to propose recommendations on the diagnosis and treatment of Systemic Mastocy-tosis in Brazil. Recommendations were based on discussions of topics and multiple-choice questions and were graded using the Oxford Centre for Evidence-Based Medicine 2011 Lev-els of Evidence Chart. Conclusion: Twenty-two recommendations or suggestions were proposed based on a litera-ture review and graded according to the findings.(c) 2022 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular.
Palavras-chave
Mastocytosis, Expert panel, Adults, Children, Diagnosis, Treatment
Referências
  1. Akin C, 2010, CURR ALLERGY ASTHM R, V10, P34, DOI 10.1007/s11882-009-0080-8
  2. Alvarez-Twose I, 2017, ONCOTARGET, V8, P68950, DOI 10.18632/oncotarget.10711
  3. Alvarez-Twose I, 2012, J CLIN ONCOL, V30, pE126, DOI 10.1200/JCO.2011.38.9973
  4. Anderson C, 2012, CRIT PERSP EMPIRE, P1
  5. [Anonymous], CONSENSUS OPINION AL
  6. Arock M, 2015, LEUKEMIA, V29, P1223, DOI 10.1038/leu.2015.24
  7. Avila NA, 1997, RADIOLOGY, V202, P367, DOI 10.1148/radiology.202.2.9015059
  8. Barete S, 2010, ANN RHEUM DIS, V69, P1838, DOI 10.1136/ard.2009.124511
  9. Barete S, 2015, BLOOD, V126, P1009, DOI 10.1182/blood-2014-12-614743
  10. Bjerrum OW, 2011, CURR DRUG TARGETS, V12, P433
  11. Bodemer C, 2010, J INVEST DERMATOL, V130, P804, DOI 10.1038/jid.2009.281
  12. van der Veer E, 2014, J ALLERGY CLIN IMMUN, V134, P1413, DOI 10.1016/j.jaci.2014.05.003
  13. van der Weide HY, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0956-z
  14. Vega-Ruiz A, 2009, LEUKEMIA RES, V33, P1481, DOI [10.1016/j.leukres.2008.12.020, 10.1016/j.leukres.2009.05.005]
  15. Vojvodic Aleksandra, 2019, Open Access Maced J Med Sci, V7, P3050, DOI 10.3889/oamjms.2019.772
  16. Zanoni G, 2017, CLIN EXP ALLERGY, V47, P593, DOI 10.1111/cea.12882
  17. Zettinig G, 2002, AM J ROENTGENOL, V179, P1235, DOI 10.2214/ajr.179.5.1791235
  18. Bonadonna P, 2015, ALLERGY, V70, P755, DOI 10.1111/all.12617
  19. Bonadonna P, 2021, J ALLER CL IMM-PRACT, V9, P2139, DOI 10.1016/j.jaip.2021.03.041
  20. Bonadonna P, 2016, CURR PHARM DESIGN, V22, P6862, DOI 10.2174/1381612822666160928121857
  21. Brazzelli V, 2016, PHOTODERMATOL PHOTO, V32, P238, DOI 10.1111/phpp.12248
  22. Brockow K, 2008, ALLERGY, V63, P226, DOI 10.1111/j.1398-9995.2007.01569.x
  23. Brockow K, 2014, IMMUNOL ALLERGY CLIN, V34, P283, DOI 10.1016/j.iac.2014.01.003
  24. Broderick V, 2019, LEUKEMIA RES, V77, P28, DOI 10.1016/j.leukres.2018.12.010
  25. Butterfield JH, 2004, AM J CLIN PATHOL, V121, P264, DOI 10.1309/2EWQKN00PG02JKY0
  26. Butterfield JH, 2018, IMMUNOL ALLERGY CLIN, V38, P397, DOI 10.1016/j.iac.2018.04.011
  27. Castells M, 2019, J ALLER CL IMM-PRACT, V7, P1097, DOI 10.1016/j.jaip.2019.02.002
  28. Chandesris MO, 2016, NEW ENGL J MED, V374, P2605, DOI 10.1056/NEJMc1515403
  29. Chiappetta N, 2006, SEMIN ARTHRITIS RHEU, V36, P32, DOI 10.1016/j.semarthrit.2006.03.004
  30. Coltoff A, 2019, LEUKEMIA RES, V81, P10, DOI 10.1016/j.leukres.2019.04.001
  31. de Silva D, 2021, ALLERGY, V76, P1493, DOI 10.1111/all.14580
  32. DeAngelo DJ, 2018, LEUKEMIA, V32, P470, DOI 10.1038/leu.2017.234
  33. Dhillon S, 2020, DRUGS, V80, P433, DOI 10.1007/s40265-020-01275-2
  34. Di Raimondo C, 2021, AUSTRALAS J DERMATOL, V62, pE1, DOI 10.1111/ajd.13443
  35. Djelbani-Ahmed S, 2015, EUR J NUCL MED MOL I, V42, P2013, DOI 10.1007/s00259-015-3117-3
  36. Droogendijk HJ, 2006, CANCER, V107, P345, DOI 10.1002/cncr.21996
  37. Erben P, 2014, ANN HEMATOL, V93, P81, DOI 10.1007/s00277-013-1964-1
  38. Escribano L, 1998, ANAL CELL PATHOL, V16, P151, DOI 10.1155/1998/341340
  39. Escribano L, 2009, J ALLERGY CLIN IMMUN, V124, P514, DOI 10.1016/j.jaci.2009.05.003
  40. Falchi L, 2018, IMMUNOL ALLERGY CLIN, V38, P411, DOI 10.1016/j.iac.2018.04.005
  41. Fernandes IC, 2014, AN BRAS DERMATOL, V89, P59, DOI 10.1590/abd1806-4841.20141847
  42. Foster R, 2004, J MOL GRAPH MODEL, V23, P139, DOI 10.1016/j.jmgm.2004.04.003
  43. Fricker M, 1997, J ALLERGY CLIN IMMUN, V100, P11, DOI 10.1016/S0091-6749(97)70188-X
  44. Fu ZL, 2016, CLIN NUCL MED, V41, P578, DOI 10.1097/RLU.0000000000001207
  45. Giannetti A, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57020124
  46. Giavina-Bianchi P, 2019, J ALLER CL IMM-PRACT, V7, P2089, DOI 10.1016/j.jaip.2019.01.059
  47. Gonzalez-de-Olano D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00792
  48. Gorska A, 2015, POL ARCH MED WEWN, V125, P46, DOI 10.20452/pamw.2644
  49. Gotlib J, 2018, J NATL COMPR CANC NE, V16, P1500, DOI 10.6004/jnccn.2018.0088
  50. Gotlib J, 2016, NEW ENGL J MED, V374, P2530, DOI 10.1056/NEJMoa1513098
  51. Gotlib J, 2013, BLOOD, V121, P2393, DOI 10.1182/blood-2012-09-458521
  52. Gotlib J, 2010, BLOOD, V116, P144
  53. Gulen T, 2014, CLIN EXP ALLERGY, V44, P121, DOI 10.1111/cea.12225
  54. Hagglund H, 2014, ACTA DERM-VENEREOL, V94, P583, DOI 10.2340/00015555-1788
  55. Hartmann K, 2020, J ALLERGY CLIN IMMUN, V146, P356, DOI 10.1016/j.jaci.2020.03.044
  56. Hartmann K, 2016, J ALLERGY CLIN IMMUN, V137, P35, DOI 10.1016/j.jaci.2015.08.034
  57. Hermans MAW, 2018, ALLERGY, V73, P2055, DOI 10.1111/all.13445
  58. Hermans MAW, 2017, ANN ALLERG ASTHMA IM, V119, P304, DOI 10.1016/j.anai.2017.07.022
  59. Hoermann G, 2014, ALLERGY, V69, P810, DOI 10.1111/all.12409
  60. Jarkvist J, 2020, J ALLER CL IMM-PRACT, V8, P3093, DOI 10.1016/j.jaip.2020.05.044
  61. Jennings S, 2014, J ALLER CL IMM-PRACT, V2, P70, DOI 10.1016/j.jaip.2013.09.004
  62. Jensen RT, 2000, HEMATOL ONCOL CLIN N, V14, P579, DOI 10.1016/S0889-8588(05)70298-7
  63. Lei D, 2017, J ALLER CL IMM-PRACT, V5, P1217, DOI 10.1016/j.jaip.2017.05.021
  64. Lim KH, 2009, AM J HEMATOL, V84, P790, DOI 10.1002/ajh.21561
  65. Lim KH, 2009, BLOOD, V113, P5727, DOI 10.1182/blood-2009-02-205237
  66. Mannelli F, 2021, ANN HEMATOL, V100, P337, DOI 10.1007/s00277-020-04323-9
  67. Martelli M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113987
  68. Matito A, 2018, IMMUNOL ALLERGY CLIN, V38, P351, DOI 10.1016/j.iac.2018.04.001
  69. Matito A, 2015, INT ARCH ALLERGY IMM, V167, P47, DOI 10.1159/000436969
  70. Meni C, 2015, BRIT J DERMATOL, V172, P642, DOI 10.1111/bjd.13567
  71. Morgado JMT, 2012, MODERN PATHOL, V25, P516, DOI 10.1038/modpathol.2011.192
  72. OCEBM Levels of Evidence Working Group*. OCEBM Levels of Evidence Working Group, OXFORD 2011 LEVELS E
  73. Orsolini G, 2018, IMMUNOL ALLERGY CLIN, V38, P443, DOI 10.1016/j.iac.2018.04.013
  74. Orsolini G, 2017, CALCIFIED TISSUE INT, V100, P595, DOI 10.1007/s00223-017-0241-z
  75. Ozturk K, 2021, BLOOD REV, V45, DOI 10.1016/j.blre.2020.100693
  76. Pardanani A, 2003, BLOOD, V102, P3093, DOI 10.1182/blood-2003-05-1627
  77. Pardanani A, 2021, AM J HEMATOL, V96, P508, DOI 10.1002/ajh.26118
  78. Pardanani A, 2018, BLOOD ADV, V2, P2964, DOI 10.1182/bloodadvances.2018026245
  79. Platzgummer S, 2020, EUR ANN ALLERGY CLIN, V52, P51, DOI 10.23822/EurAnnACI.1764-1489.133
  80. Reichard KK, 2015, AM J CLIN PATHOL, V144, P493, DOI 10.1309/AJCPSGQ71GJQQACL
  81. Romantowski J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031454
  82. Rossini M, 2016, OSTEOPOROSIS INT, V27, P2411, DOI 10.1007/s00198-016-3539-1
  83. Rossini M, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2014.06.015
  84. Rossini M, 2011, BONE, V49, P880, DOI 10.1016/j.bone.2011.07.004
  85. Sanchez-Munoz L, 2011, MODERN PATHOL, V24, P1157, DOI 10.1038/modpathol.2011.84
  86. Sandru F, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071474
  87. Schuch A, 2017, IMMUNOL ALLERGY CLIN, V37, P153, DOI 10.1016/j.iac.2016.08.017
  88. Schwartz LB, 2000, HEMATOL ONCOL CLIN N, V14, P641, DOI 10.1016/S0889-8588(05)70300-2
  89. Shomali W, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22062983
  90. Siegert SI, 2004, AM J CLIN PATHOL, V122, P560, DOI 10.1309/2880LF7Q6XK3HA3Q
  91. Soter NA, 2000, HEMATOL ONCOL CLIN N, V14, P537, DOI 10.1016/S0889-8588(05)70295-1
  92. Sotlar K, 2002, LEUKEMIA RES, V26, P979, DOI 10.1016/S0145-2126(02)00041-3
  93. Sotlar K, 2003, AM J PATHOL, V162, P737, DOI 10.1016/S0002-9440(10)63870-9
  94. Soverini S, 2021, LANCET HAEMATOL, V8, pE164, DOI 10.1016/S2352-3026(20)30432-4
  95. Sperr WR, 2002, INT ARCH ALLERGY IMM, V128, P136, DOI 10.1159/000059404
  96. Tzankov A, 2021, AM J CLIN PATHOL, V155, P239, DOI [10.1093/AJCP/AQAA183, 10.1093/ajcp/aqaa183]
  97. Ustun C, 2011, LEUKEMIA RES, V35, P1143, DOI 10.1016/j.leukres.2011.05.006
  98. Valent P, 2019, INT ARCH ALLERGY IMM, V180, P44, DOI 10.1159/000501079
  99. Valent P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122976
  100. Valent P, 2017, BLOOD, V129, P1420, DOI 10.1182/blood-2016-09-731893
  101. Valent P, 2017, CANCER RES, V77, P1261, DOI 10.1158/0008-5472.CAN-16-2234
  102. Van den Wyngaert T, 2016, EUR J NUCL MED MOL I, V43, P1723, DOI 10.1007/s00259-016-3415-4